NEOGENOMICS INC — Director's Dealing 2019

Aug 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-08-28

Reporting Person: Bonello William (Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-28	Common Stock	M	17000	$7.52	Acquired	23735	Direct
2019-08-28	Common Stock	S	17000	$24.83	Disposed	6735	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-28	Stock Option (Right to Buy)	$7.52	M	17000	Disposed	2022-04-28	Common Stock (72763.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (41167.0)	41167	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (80334.0)	80334	Direct

Footnotes

F1: On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.

F2: On March 1, 2019, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.

F3: On February 26, 2018, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.